Development of tolerance upon repeated administration with the GABA receptor positive allosteric modulator, COR659, on alcohol drinking in rodents.

Recent work has demonstrated that acute administration of the novel positive allosteric modulator of the GABA receptor, COR659, reduces several alcohol-related behaviors in rodents. To assess whether COR659 continues to lessen alcohol intake after repeated administration, a fundamental feature of drugs with therapeutic potential. Male C57BL/6J mice (n = 40) were exposed to daily 2-hour drinking sessions (20% (v/v) alcohol) under the 1-bottle "drinking in the dark" protocol and male Sardinian alcohol-preferring rats (n = 40) were exposed to daily 1-hour drinking sessions under the 2-bottle "alcohol (10%, v/v) vs water" choice regimen.

Reducing effect of the novel positive allosteric modulator of the GABA receptor, COR659, on binge-like alcohol drinking in male mice and rats.

Rationale: Binge drinking (BD) is a widespread drinkingpattern that may contribute to promote the development of alcohol use disorder (AUD). The comprehension of its neurobiological basis and the identification of molecules that may prevent BD are critical. Preclinical studies demonstrated that positive allosteric modulators (PAMs) of the GABA receptor effectively reduced, and occasionally suppressed, the reinforcing and motivational properties of alcohol in rodents, suggesting their potential use as pharmacotherapy for AUD, including BD.